To assess efficacy, safety and pharmacokinetics (PK) of oral lenacapavir (LEN) when used as oral bridging (OB) between delayed subcutaneous (SC) LEN injections.#Post-hocanalysis of participants in two clinical trials of SC LEN for HIV-1 treatment who required OB when LEN SC dosing was ...